Opioids have been used for the treatment of chronic pain for centuries and regarded as among the most powerful drugs for the treatment of chronic pain. For the most part when managed appropriately, opioid therapy is considered to improve patient’s quality of life. However, opioid medications are addictive and have the potential to cause adverse social, financial, mental, and economic consequences. Studies have shown that up to 45% of patients with chronic pain on opioid therapy reported drug-related behaviors.
Burpenorphine is a great alternative to opioids due to its low incidence of addiction and respiratory failure. Buprenorphine is an opioid partial agonists that provides 24 hour pain relief with as little as two doses a day. Buprenorphine is offered in transdermal patch, sublingual, buccal preparations.